Genitourinary Malignancies /

Neal Shore, MD, FACS

27:14

Presentation on Recent Advances in the Treatment of mHSPC and nmCRPC: New Options to Delay Progression to mCRPC from ASCO 2019 satellite symposium.

Genitourinary Malignancies

Presentation on Recent Advances in the Treatment of mHSPC and nmCRPC: New Options to Delay Progression to mCRPC from ASCO 2019 satellite symposium.

Genitourinary Malignancies Similar Videos

Similar Videos

Jacob Berchuck, MD; Dana-Farber Cancer Institute; 5Live #GU22

5:13

Key Insights from the ASCO Genitourinary Cancers Symposium #GU22
Thomas Hutson, DO, PharmD, FACP; Texas Oncology; 5Live; #ASCOGU21

8:27
Bradley A. McGregor, MD; Dana-Farber Cancer Institute; 5Live; #ASCOGU21

7:14

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611